<?xml version="1.0" encoding="UTF-8"?>
<p>Chloroquine and hydroxychloroquine are relatively well tolerated and has been used for ages in patients with systemic lupus erythematosus (SLE) and malaria. However, both agents can cause serious adverse effects (&lt; 10%), like hypoglycemia, retinopathy, psychiatric effects, QTc prolongation. Azithromycin is a commonly used macrolide for respiratory bacterial infections. Gautret et al concluded that combination therapy with azithromycin and hydroxychloroquine cured 100% of patients virologically on day 6 compared to 57.1% in patients treated with hydroxychloroquine only, and 12.5% in the control group (P = 0.001) [
 <xref rid="R25" ref-type="bibr">25</xref>]. However, the risk of QT prolongation from these two drugs should be considered, and caution should be taken, especially in cardiac patients, while administering this combination [
 <xref rid="R26" ref-type="bibr">26</xref>]. Moreover, a study among 368 USA veterans found no benefit, rather touted hydroxychloroquine to be more harmful due to its side effect profile [
 <xref rid="R27" ref-type="bibr">27</xref>].
</p>
